Screener
Sylvamo SLVM Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 20.6%-2.4pp | 21.3%-3.3pp | 21.9%-3.0pp | 22.5%-1.7pp | 23%-0.8pp | |
| Net margin | 2.3%-3.8pp | 3.1%-4.6pp | 3.9%-4.1pp | 5.2%-1.9pp | 6.1%-0.2pp | |
| Returns | ||||||
| Return on equity | 7.9%-16.4pp | 10.8%-21.0pp | 14.6%-20.0pp | 18.8%-11.6pp | 24.4%-3.2pp | |
| Return on invested capital | 4.3%-8.7pp | 6.1%-10.9pp | 8.2%-10.7pp | 10.6%-5.9pp | 13.1%-0.7pp | |
| Efficiency | ||||||
| Asset turnover | 1.2×-0.1× | 1.2×-0.2× | 1.2×-0.1× | 1.2×-0.1× | 1.3×0.0× | |
| Liquidity | ||||||
| Current ratio | 1.5×-0.1× | 1.4×-0.2× | 1.5×-0.1× | 1.5×-0.2× | 1.5×-0.1× | |
| Leverage | ||||||
| Debt-to-equity | 1×+0.1× | 0.9×-0.1× | 0.9×-0.2× | 0.9×-0.2× | 0.9×-0.3× | |
| Net debt / EBITDA | 2.6×+1.0× | 2.2×+0.8× | 1.9×+0.7× | 1.9×+0.5× | 1.7×0.0× | |
| Valuation | ||||||
| Market capitalization | $1.5B-22.2% | $1.67B-38.6% | $1.9B-41.4% | $1.79B-49.3% | $2.08B-26.3% | |
| Price / earnings | 19.8×+10.9× | 16.4×+6.9× | 14.4×+3.7× | 9.9×-3.1× | 9.5×-2.6× | |
| Price / sales | 0.5×-0.1× | 0.5×-0.2× | 0.6×-0.3× | 0.5×-0.4× | 0.6×-0.2× | |
| Price / book | 1.6×-0.4× | 1.7×-1.3× | 2×-1.9× | 1.8×-1.9× | 2.2×-1.2× | |
| EV / EBITDA | 7.3×+1.4× | 7.1×+0.6× | 6.9×0.0× | 6.1×-1.9× | 6.3×-1.3× | |
| Dividend yield | 4.9%+1.1pp | 4.4%+1.9pp | 3.8%+1.9pp | 4.1%+2.2pp | 3.5%+1.4pp |
FAQ
- Where do Sylvamo's ratios come from?
- Every ratio is computed from Sylvamo's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
